| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 27 | +29.63% | +2.62% | +0.75% | +1.87% | +1.49% | — |
| 14d | 27 | +25.93% | +2.77% | +1.10% | +1.67% | +1.27% | — |
| 30d | 27 | +55.56% | -0.23% | +1.16% | -1.38% | -0.74% | — |
| 60d | 27 | +66.67% | -5.20% | -0.98% | -4.22% | -9.03% | — |
| 90d | 27 | +59.26% | -5.80% | +1.15% | -6.95% | +3.62% | — |
| 180d | 27 | +59.26% | -7.29% | +6.49% | -13.78% | -16.85% | — |
| 1y | 27(1 pending) | +69.23% | -18.64% | +16.65% | -35.28% | -59.09% | — |
| 2y | 27(3 pending) | +83.33% | -21.24% | +26.45% | -47.69% | -45.79% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| REPL REPLIMUNE GROUP, INC. | SALE Chief Financial Officer | 7,812 | $5.08 | $39.7K | 236,556 | May 18, 2026 | May 20, 2026 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Apr 1, 2026 | Apr 7, 2026 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 244,368 | Apr 1, 2026 | Apr 7, 2026 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 194,368 | Dec 19, 2025 | Dec 19, 2025 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | SALE Chief Financial Officer | 9,154 | $5.37 | $49.2K | 134,368 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | SALE Chief Financial Officer | 2,535 | $8.05 | $20.4K | 143,522 | May 20, 2025 | May 22, 2025 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 67,500 | — | — | 67,500 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 146,057 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | SALE Chief Financial Officer | 8,938 | $10.18 | $91.0K | 101,057 | Aug 16, 2024 | Aug 19, 2024 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 26,665 | — | — | 109,995 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 83,330 | — | — | 83,330 | Sep 18, 2023 | Sep 20, 2023 ↗ | View → |
| REPL REPLIMUNE GROUP, INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Sep 18, 2023 | Sep 20, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,363 | $45.00 | $331.3K | 38,925 | Mar 27, 2023 | Mar 29, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 575 | $45.63 | $26.2K | 46,288 | Jan 31, 2023 | Feb 2, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 223 | $47.45 | $10.6K | 46,863 | Jan 24, 2023 | Jan 26, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 418 | $44.36 | $18.5K | 47,086 | Jan 11, 2023 | Jan 12, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 497 | $42.93 | $21.3K | 47,504 | Jan 10, 2023 | Jan 12, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 758 | $41.66 | $31.6K | 48,001 | Jan 9, 2023 | Jan 11, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 48,759 | Jan 5, 2023 | Jan 9, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,500 | — | — | 42,500 | Jan 5, 2023 | Jan 9, 2023 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE CHIEF FINANCIAL OFFICER | 7,910 | $37.78 | $298.8K | 29,259 | Mar 31, 2022 | Apr 1, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 553 | $40.00 | $22.1K | 37,169 | Feb 1, 2022 | Feb 3, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 211 | $39.31 | $8.3K | 37,722 | Jan 25, 2022 | Jan 27, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,600 | — | — | 37,933 | Jan 7, 2022 | Jan 11, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 58,500 | — | — | 58,500 | Jan 7, 2022 | Jan 11, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 800 | $38.53 | $30.8K | 22,333 | Jan 7, 2022 | Jan 11, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 173 | $41.16 | $7.1K | 23,133 | Jan 4, 2022 | Jan 6, 2022 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 541 | $56.96 | $30.8K | 23,306 | Feb 1, 2021 | Feb 2, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 275 | $62.05 | $17.1K | 23,847 | Jan 25, 2021 | Jan 27, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,825 | $11.23 | $43.0K | 0 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,500 | $18.01 | $189.1K | 3,500 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,825 | $11.23 | $43.0K | 27,947 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,500 | $18.01 | $189.1K | 34,622 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 9,278 | $33.02 | $306.4K | 33,400 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 2,430 | $30.86 | $75.0K | 26,552 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,430 | $69.75 | $169.5K | 24,122 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 9,278 | $33.02 | $306.4K | 11,932 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,825 | $69.75 | $266.8K | 24,122 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 9,278 | $69.75 | $647.1K | 24,122 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,500 | $69.75 | $732.4K | 24,122 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,430 | $30.86 | $75.0K | 0 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 63,000 | — | — | 63,000 | Jan 6, 2021 | Jan 8, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,800 | — | — | 24,122 | Jan 6, 2021 | Jan 8, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 176 | $62.37 | $11.0K | 13,322 | Jan 5, 2021 | Jan 7, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 112 | $62.37 | $7.0K | 13,498 | Jan 5, 2021 | Jan 7, 2021 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,581 | $52.50 | $135.5K | 13,610 | Jun 29, 2020 | Jul 1, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,300 | — | — | 16,191 | Jan 29, 2020 | Jan 31, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 64,250 | — | — | 64,250 | Jan 29, 2020 | Jan 31, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 330 | $53.25 | $17.6K | 6,891 | Jan 23, 2020 | Jan 27, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 63 | $49.62 | $3.1K | 7,221 | Jan 7, 2020 | Jan 8, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 121 | $48.17 | $5.8K | 7,484 | Jan 6, 2020 | Jan 8, 2020 ↗ | View → |
| PTCT PTC THERAPEUTICS, INC. | SALE Chief Financial Officer | 200 | $48.17 | $9.6K | 7,284 | Jan 6, 2020 | Jan 8, 2020 ↗ | View → |